Effect of Vitreomacular Adhesion on Treatment Outcomes in the Ranibizumab for Edema of the Macula in Diabetes (READ-3) Study

Ophthalmology

Volumn 123, Issue 2, 2016, Pages 324-329

  Sadiq, Mohammad Ali ^a   Soliman, Mohamed Kamel ^a,e   Sarwar, Salman ^a   Agarwal, Aniruddha ^a   Hanout, Mostafa ^a   Demirel, Sibel ^b   Rentiya, Zubir S ^c   Khan, Waqar ^c,d   Do, Diana V ^a   Nguyen, Quan Dong ^a   Sepah, Yasir J ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b ANKARA UNIVERSITY   (Turkey)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^e ASSIUT UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; ANGIOGENESIS INHIBITOR; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ARTICLE; BEST CORRECTED VISUAL ACUITY; CENTRAL RETINAL THICKNESS; DIABETIC MACULAR EDEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPTICAL COHERENCE TOMOGRAPHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULOPATHY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VISUAL ACUITY; VITREOMACULAR ADHESION; VITREOUS BODY DETACHMENT; AGED; ANTAGONISTS AND INHIBITORS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC RETINOPATHY; INTRAVITREAL DRUG ADMINISTRATION; MACULAR EDEMA; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA DISEASE; TISSUE ADHESION;

AGED; ANGIOGENESIS INHIBITORS; DIABETIC RETINOPATHY; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RANIBIZUMAB; RETINAL DISEASES; RETROSPECTIVE STUDIES; TISSUE ADHESIONS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS DETACHMENT;

EID: 84951837328     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2015.09.032     Document Type: Article

References (18)

1. Q.D. Nguyen, S. Tatlipinar, S.M. Shah, and et al. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema Am J Ophthalmol 142 2006 961 969
2. Q.D. Nguyen, S.M. Shah, J.S. Heier, and et al. Primary end point (six months) results of the Ranibizumab for Edema of the Macula in Diabetes (READ-2) study Ophthalmology 116 2009 2175 2181e2171
3. Q.D. Nguyen, S.M. Shah, A.A. Khwaja, and et al. Two-year outcomes of the Ranibizumab for Edema of the Macula in Diabetes (READ-2) study Ophthalmology 117 2010 2146 2151
4. M.J. Elman, A. Ayala, N.M. Bressler, and et al. Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results Ophthalmology 123 2015 375 381
5. R. Channa, R. Sophie, A.A. Khwaja, and et al. Factors affecting visual outcomes in patients with diabetic macular edema treated with ranibizumab Eye (Lond) 28 2014 269 278
6. S.B. Bressler, H. Qin, R.W. Beck, and et al. Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab Arch Ophthalmol 130 2012 1153 1161
7. C.-K. Chang, C.-K. Cheng, C.-H. Bai, and et al. Development of vitreomacular interface abnormality in patients with diabetic macular edema Taiwan J Ophthalmol 2 2012 93 98
8. N.R. Kim, Y.J. Kim, H.S. Chin, and Y.S. Moon Optical coherence tomographic patterns in diabetic macular oedema: prediction of visual outcome after focal laser photocoagulation Br J Ophthalmol 93 2009 901 905
9. J.S. Duker, P.K. Kaiser, S. Binder, and et al. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole Ophthalmology 120 2013 2611 2619
10. D.V. Do, Y.J. Sepah, D. Boyer, and et al. Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 with High Dose) Eye (Lond) 2015 Jul 31 10.1038/eye.2015.142 [Epub ahead of print]
11. J. Sebag Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal disease Graefes Arch Clin Exp Ophthalmol 242 2004 690 698
12. F.P. Nasrallah, A.E. Jalkh, F. Van Coppenolle, and et al. The role of the vitreous in diabetic macular edema Ophthalmology 95 1988 1335 1339
13. T. Hikichi, N. Fujio, J. Akiba, and et al. Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus Ophthalmology 104 1997 473 478
14. E. Stefansson Ocular oxygenation and the treatment of diabetic retinopathy Surv Ophthalmol 51 2006 364 380
15. E. Stefansson The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology Acta Ophthalmol Scand 79 2001 435 440
16. U. Stolba, S. Binder, D. Gruber, and et al. Vitrectomy for persistent diffuse diabetic macular edema Am J Ophthalmol 140 2005 295 301
17. C.E. Veloso, T.M. Kanadani, F.B. Pereira, and M.B. Nehemy Vitreomacular interface after anti-vascular endothelial growth factor injections in neovascular age-related macular degeneration Ophthalmology 122 2015 1569 1572
18. R. Terao, K. Yuda, K. Kure, and et al. Effect of vitreomacular adhesion on antivascular endothelial growth factor therapy for macular edema secondary to branch retinal vein occlusion Jpn J Ophthalmol 58 2014 139 145